학술논문
FP.22 Results from the end of Part A of the ongoing 3-part DEVOTE study to explore higher doses of nusinersen in SMA
Document Type
Abstract
Author
Source
In Neuromuscular Disorders October 2022 32 Supplement 1:S85-S85
Subject
Language
ISSN
0960-8966